BeneFIX is a Kit in the Plasma Derivative category. It is labeled and distributed by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc. The primary component is .
Product ID | 58394-636_21a8f583-c575-428c-9a0a-dfc39445dfcc |
NDC | 58394-636 |
Product Type | Plasma Derivative |
Proprietary Name | BeneFIX |
Generic Name | Coagulation Factor Ix (recombinant) |
Dosage Form | Kit |
Marketing Start Date | 2007-07-06 |
Marketing Category | BLA / BLA |
Application Number | BLA103677 |
Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2007-07-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103677 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2007-07-06 |
NDC | Brand Name | Generic Name |
---|---|---|
58394-633 | BeneFIX | coagulation factor ix (recombinant) |
58394-634 | BeneFIX | coagulation factor ix (recombinant) |
58394-635 | BeneFIX | coagulation factor ix (recombinant) |
58394-637 | BeneFIX | BeneFIX |
58394-636 | BeneFIX | BeneFIX |
0944-3026 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3028 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3030 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3032 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3034 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BENEFIX 87367180 5410614 Live/Registered |
BeneFix, LLC 2017-03-10 |
BENEFIX 87367107 5410613 Live/Registered |
BeneFix, LLC 2017-03-10 |
BENEFIX 78872293 3217619 Live/Registered |
SS&C TECHNOLOGIES, INC. 2006-04-28 |
BENEFIX 75376195 2413376 Dead/Cancelled |
2900084 CANADA INC. 1997-10-20 |
BENEFIX 75038324 2102082 Live/Registered |
GENETICS INSTITUTE, LLC 1995-12-26 |
BENEFIX 74377205 1814054 Dead/Cancelled |
Blue Cross and Blue Shield 1993-04-09 |